Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01757431

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Atypical Hemolytic Uremic Syndrome (aHUS) Clinical Trial

Clinical Trial Summary

Protocol is intended to characterize the overall safety and tolerability of eculizumab in this population.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01757431
Study type Interventional
Source Alexion Pharmaceuticals
Contact
Status Completed
Phase Phase 2
Start date May 16, 2012
Completion date September 25, 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT01755429 - To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients N/A
Not yet recruiting NCT06312644 - Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Completed NCT02949128 - Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Phase 3
Completed NCT03131219 - Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) Phase 3
Completed NCT01770951 - A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)